Ken Fisher
PGNX

Ken Fisher’s Progenics Pharmaceuticals Inc PGNX Stock Holding History

Ken Fisher’s Portfolio PGNX Stock Details PGNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-105,125
Closed -$399K – 869
2020
Q1 		$399K Hold
105,125
– – ﹤0.01% 647
2019
Q4 		$535K Hold
105,125
– – ﹤0.01% 652
2019
Q3 		$531K Hold
105,125
– – ﹤0.01% 679
2019
Q2 		$649K Hold
105,125
– – ﹤0.01% 639
2019
Q1 		$488K Sell
105,125
-300
-0.3% -$1.36K ﹤0.01% 646
2018
Q4 		$443K Buy
105,425
+300
+0.3% +$1.53K ﹤0.01% 663
2018
Q3 		$659K Sell
105,125
-26,736
-20% -$205K ﹤0.01% 619
2018
Q2 		$1.06M Sell
131,861
-171,831
-57% -$1.31M ﹤0.01% 580
2018
Q1 		$2.27M Hold
303,692
– – ﹤0.01% 513
2017
Q4 		$1.81M Buy
303,692
+51,762
+21% +$314K ﹤0.01% 529
2017
Q3 		$1.85M Buy
251,930
+89,808
+55% +$570K ﹤0.01% 513
2017
Q2 		$1.1M Buy
162,122
+64,490
+66% +$476K ﹤0.01% 529
2017
Q1 		$922K Buy
97,632
+18,604
+24% +$186K ﹤0.01% 512
2016
Q4 		$683K Sell
79,028
-28,635
-27% -$212K ﹤0.01% 535
2016
Q3 		$682K Sell
107,663
-32,698
-23% -$198K ﹤0.01% 540
2016
Q2 		$754K Buy
140,361
+170
+0.1% +$821 ﹤0.01% 531
2016
Q1 		$683K Hold
140,191
– – ﹤0.01% 543
2015
Q4 		$859K Buy
140,191
+56,941
+68% +$373K ﹤0.01% 525
2015
Q3 		$476K Buy
+83,250
New +$639K ﹤0.01% 553

Other funds holding PGNX

ECM
Everence Capital Management Goshen, Indiana $1.64B AUM 26.46% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return
Daiwa Securities Group
Daiwa Securities Group Tokyo, Japan $34.8B AUM 20.7% 1-Year Est. Return

Ken Fisher's PGNX Position: Q2 2020 in Review

Ken Fisher sold out of Progenics Pharmaceuticals Inc (PGNX) in Q2 2020, closing a stake of 105,125 shares — an estimated $399K sold.

Ken Fisher first reported a position in PGNX in Q3 2015 and held it in 19 quarters. The position peaked at $2.27M in Q1 2018. 3 funds tracked by Wall St. Rank hold PGNX as of Q2 2020.

  • Ken Fisher reported no remaining Progenics Pharmaceuticals Inc position as of Q2 2020 after selling out during the quarter.
  • Ken Fisher sold 105,125 Progenics Pharmaceuticals Inc shares in Q2 2020, an estimated $399K.
  • Ken Fisher first reported a position in Progenics Pharmaceuticals Inc in Q3 2015 and held it in 19 quarters.
  • Ken Fisher's Progenics Pharmaceuticals Inc position peaked at $2.27M in Q1 2018.
  • 3 funds tracked by Wall St. Rank held Progenics Pharmaceuticals Inc as of Q2 2020.

Based on Fisher Asset Management's 13F filing for Q2 2020, filed 7 Aug 2020.